Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor and G-CSF for Stem Cell Mobilisation in NHL, HD, or MM
NCT00838357Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of plerixafor in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), multiple myeloma (MM), sponsored by Sanofi. Started Sep 2008; status: completed.
02
Drugs
plerixafor
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00838357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838357.